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attention as a minimally invasive and alternative
approach to conventional operation. By avoiding ster-
notomy in favor of a small anterior thoracotomy, mini-
mally invasive direct coronary artery bypass grafting
(MIDCAB) rapidly attracted interest as a new tech-
nique, albeit limited mostly to patients with single-ves-
sel disease.2 Consequently, the surgeons’ focus in mini-
mally invasive technique rapidly shifted toward the
avoidance of cardiopulmonary bypass (CPB) rather
than the sternotomy itself to potentially treat the signif-
icantly larger number of patients affected with multi-
vessel disease. Long considered the gold standard,
CPB-supported coronary operations are recently being
questioned because the procedure is still characterized
by a significant number of side effects.3,4
Initially, the beating heart operative technique was
deemed to be more technically demanding; however,
the recent introduction and continuous improvement in
D uring the past few years, an increasing number ofsurgeons have rehabilitated the practice of unsup-
ported beating heart coronary operations for select
groups of patients. Popularized by Kolesov1 in the early
1960s, the technique has recently regained surgeons’
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SYSTEMATIC OFF-PUMP CORONARY ARTERY REVASCULARIZATION IN MULTIVESSEL DISEASE:
EXPERIENCE OF THREE HUNDRED CASES
coronary mechanical stabilizers has considerably
improved the feasibility and outcome of these proce-
dures. Although the beating heart operative technique
was shown to be a suitable alternative to conventional
CPB operations in select patients carrying high surgical
risk, it has not been considered on a systematic basis
for a majority of patients.5
To qualify as an alternative approach to conventional
operations, beating heart operations must respond to all
anatomies, use similar vascular conduits, achieve
equivalent technical results and comparable mortality
and morbidity rates, and maintain a low conversion rate
to on-pump operations. Furthermore, the ability to pro-
vide the patient with as complete a coronary revascu-
larization as possible should not be compromised
through the beating heart operation approach because
this represents a major benefit for the patient.6,7 Since
October 1996, we have developed and adopted the
practice of systematic off-pump coronary artery revas-
cularization at the Montreal Heart Institute. This report
describes our experience with this technique while
comparing it with conventional CPB operations.
Patients and methods
Between October 1996 and December 1998, we completed
300 coronary artery revascularizations without CPB, the
majority (>270 cases) of which were systematically
approached, meaning that all patients were considered for the
beating heart operation technique. This represents 94% of the
coronary revascularization caseload during this same period,
and 97% of all procedures were performed during 1998.
These patients were prospectively followed up and compared
with a control cohort of 1870 patients operated on with CPB
during 1995 and 1996 by all cardiac surgeons working at the
Montreal Heart Institute during this period. All off-pump
operations were done by a single surgeon (R.C.). The CPB
cohort was selected from this earlier period to segregate post-
1996 off-pump beating heart operations and be demographi-
cally representative of a standard cohort of surgical patients.
After 1996, a significant number of coronary revasculariza-
tions were completed off-pump at our institution. All salvage
procedures were excluded in both groups. Salvage proce-
dures were defined as patients rushed into the operating room
with unstable hemodynamics or severe ischemia that could
not be stabilized preoperatively. These patients, because of
their unstable preoperative hemodynamics, had to be operat-
ed on in conjunction with CPB. Fifty-six (2.9%) of these
patients were excluded from the CPB group.
Surgical contraindications for beating heart operations.
After the first 30 off-pump bypass procedures, all patients
were considered as potential candidates. Only patients (<1%)
with deep intramyocardial left anterior descending (LAD)
arteries or with very unstable preoperative hemodynamics
were not considered for the procedure. Reoperative proce-
dures, during which patent but atheromatous grafts fed
occluded native coronary arteries, were considered relative
contraindications if partial aortic clamping of the ascending
aorta was anticipated, thereby causing a potential ischemic
threat.
Off-pump surgical technique. The technique we used has
already been described.8,9 In brief, most of the procedures
(>99%) were approached through a standard sternotomy
under general anesthesia (narcotics, benzodiazepines, and
pancuronium). Occasional boluses of metoprolol were
administered to maintain heart beat below 80 beats/min when
indicated. Pressure drop and electrocardiographic ST-seg-
ment modifications were treated with infusion of phenyl-
ephrine and nitroglycerin, respectively, as indicated.
The distal right artery and the LAD artery were directly
accessed with very little heart manipulation. The posterior
descending artery (PDA) and the obtuse marginal artery were
accessed by more extensive mobilization of the posterior
pericardium. For the circumflex territory, this consisted in
positioning 4 traction sutures spaced between the left superi-
or pulmonary vein and the inferior vena cava (Fig 1). The
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Fig 1. The site of the pericardial stitches used to verticalize
the heart. The first stitch (1) is located between the superior
and the inferior left pulmonary veins close to the pericardial
reflection (<1 cm from the vein bifurcation). The second
stitch (2) is placed below the left inferior pulmonary vein.
Once the first 2 stitches are anchored, a pericardial “ridge” is
formed, which serves as a guide for implantation of the other
stitches. The third stitch (3) is located between the second
and the inferior vena cava, and the last stitch (4) is located
close to the inferior vena cava. A, Aorta; PA, pulmonary
artery; LA, left atrium.
sutures were placed far below the phrenic nerve at the level
of the pericardial reflection. No pericardial counterincision to
create heart herniation through the right chest was used and
in none of the cases was the need for a right ventricular assist
device necessitated. Vessel occlusion was achieved through
external encircling with silicone rubber bands (Retract-o-
tape; Quest Medical Inc, Allen, Tex). No intraluminal occlu-
sive device, shunt, or gas insufflation was used. Coronary
artery immobilization was achieved with specially designed
reusable mechanical stabilizers (Cor-Vasc System [patent
pending]; CoroNéo Inc, Montreal, Canada; Fig 2, A and B).
The following revascularization strategy was adopted: the
most collateralized vessel was always bypassed first to pro-
vide a backup to the less severely stenotic vessels; all proxi-
mal anastomoses were completed during a single partial
clamping of the aorta; and the PDA was generally favored
over the distal right coronary artery to avoid atrioventricular
block.
On-pump surgical technique. Coronary revascularization
with CPB was performed under moderate hypothermia
(32°C-34°C) with a membrane oxygenator (Monolyth; Sorin
Biomedica, Inc, Richmond Hill, Canada) equipped with an
arterial air filter (Terumo; CardioMed Supplies, Inc,
Gormley, Canada). Cardioplegic arrest was achieved with a
hyperkalemic cold cardioplegic blood solution. In the major-
ity of patients, the CPB circuit was primed with crystalloid
solution.
Follow-up. Short-term (3 months) follow-up was complet-
ed on 99% of the beating heart operation group. However,
midterm (>6 months) follow-up was completed only in 30%
of the patients.
Statistics. Data are expressed as mean values ± SD.
Comparisons between the two groups are established with
unpaired t tests (2-tailed) for continuous variables and with
the χ2 and Fisher exact tests for discrete variables. For data
presenting skewed distribution, results are expressed as the
median and 25th and 75th percentiles along with minimum
and maximum, and the Kruskal-Wallis test is used for statis-
tical comparisons. For continuous variables studied in differ-
ent time frames, a 2-way analysis of variance for repeated
measures on factor time was used.
Results
Demographics and risk factors. The two groups
were comparable in terms of age, sex distribution, and
standard risk factors, except for the prevalence of
unstable angina, which was higher in the CPB group
(Table I). Similarly, the preoperative left ventricular
ejection fraction (LVEF), the prevalence of left ventric-
ular dysfunction as defined by an LVEF of less than
40%, previous coronary operations, significant left
main disease, and the use of a preoperative intra-aortic
counterpulsation device were the same for both popu-
lations.
Perioperative technical data. The average number
of grafts per patient, as well as the graft distribution,
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Fig 2. A, The posterior wall stabilizer positioned for completion of a second obtuse marginal graft. B, CoroNéo
Cor-Vasc device used for posterior wall stabilization.
are displayed in Table II. A trend toward a higher num-
ber of grafts was observed in the beating heart opera-
tion group (P = .057), and this is reflected in the graft
distribution. The rate of complete revascularization
achieved in the beating heart operation group was 93%.
Revascularization was considered incomplete when a
territory was judged surgically nonreconstructable or
when a suitable vessel was discarded for technical rea-
sons. Only one conversion to CPB was necessitated in
the beating heart operation group, and this was subse-
quent to a side-clamping related aortic dissection. The
patient underwent an ascending aortic replacement
with a Dacron graft and had an uneventful recovery.
The average ischemic interval relative to the revascu-
larized territory is presented in Table III. On average,
the use of arterial and vein conduits was comparable in
both groups (Table IV). The use of the radial artery as
a conduit was only introduced in our institute after
1996. Coronary endarterectomies, with or without vein
patch angioplasty, were completed in 9% of the beating
heart operation group.
Postoperative bleeding and transfusion needs.
Perioperative blood loss was significantly lower in the
beating heart operation group. A tremendous difference
was observed in the transfusion needs between both
groups (Table V). The beating heart operation group
was transfused half as often as the CPB group.
Furthermore, among the patients who received a trans-
fusion, red cell pack requirements were similar for the
two groups, whereas the amount of blood products
administered, including fresh frozen plasma, platelet
packs, or cryoprecipitates, were significantly less in the
beating heart operation group.
Hematology and biochemistry. These two profiles
are presented in Table VI. The postoperative and dis-
charge hemoglobin count was significantly higher in
the beating heart operation group. The postoperative
creatinine serum level rose more significantly in the
CPB group. The average postoperative cardiac subunit
creatine kinase MB (CK-MB) was also significantly
lower in the beating heart operation group the day of
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Table I. Demographics and perioperative risk factors
Beating heart 
operation CPB 
(n = 300) (n = 1870) P value
Age (y) 63 ± 10 62.5 ± 10 .4
Sex ratio (M/F) 3.47 3.34 .4
Diabetes 24% 24% .95
HBP 48% 46% .12
Tobacco 33% 29% .18
COPD 9% 8% .6
LVEF 54% ± 10% 54% ± 13% 1.00
LVEF < 40% 15% 16% .7
Previous operation 7% 8% .2
Unstable angina 60% 69% .002
LMS > 50% 26% 22% .14
Preoperative IABP 5% 5% .9
HBP, High blood pressure; COPD, chronic obstructive pulmonary disease;
LMS, left main stenosis; IABP, intra-aortic balloon pump.
Table II. Technical data
Beating heart 
operation CPB 
(n = 300) (n = 1870) P value
Grafts per patient 2.93 ± 0.87 2.84 ± 0.74 .06
Ischemic time (min) 28 ± 11 45 ± 17 .001
Graft distribution
Single 5% 2.3% .02
Double 23.3% 29% .04
Triple 47% 52% .12
Quadruple 22% 16% .01
Quintuple 2.7% 0.7% .003
Coronary territory grafted
LAD 95% 95% .9
Diagonal 30% NA
Circumflex 73% 63% .001
Right 78% 73% .08
Complete 93% NA
revascularization
Conversion rate to CPB 0.4%
NA, Not available.
Table III. Ischemic interval relative to revascularized
territory
Median* 25th–75th 
Artery (minimum-maximum) percentile
LAD 9 (4-43) 8-12
Diagonal 8 (4-32) 6-9
Obtuse marginal 8 (4-45) 7-10
Posterior descending 8 (4-23) 6-10
Right coronary 8 (5-19) 7-11
Posterolateral 7.5 (5-16) 7-10
*In minutes.
Table IV. Vascular conduits
Beating heart 
operation CPB 
Conduits (n = 300) (n = 1870) P value
Internal thoracic artery 96% 93% .07
Radial artery 12% 0%*
Saphenous vein 84% 94% .001
*No radial artery grafts were used in our institution before 1997.
the operation and the following day. By the second
postoperative day, there no longer was a significant
difference.
Postoperative morbidity rates. The list of the most
common perioperative complications for both groups is
presented in Table VII. The incidence of myocardial
infarction (MI; Q and non-Q wave) was equivalent in
the two cohorts. MI was defined as either a maximal
CK-MB level of greater than 100 IU/L, any new abnor-
mal wall motion detected by echocardiography not pre-
sent before the operation, or a positive technetium
pyrophosphate radionucleide scan. Interestingly, the
incidence of atrial fibrillation and cerebrovascular acci-
dent remained similar in the two groups. The use of
postoperative inotropic agents was the same in the two
groups. A trend toward a shorter postoperative hospital
stay was observed in the beating heart operation group.
Postoperative mortality rate. The operative mortal-
ity rate was 1.3% and 2% in the beating heart operation
and CPB groups, respectively. Causes of death in the
beating heart operation group (4 patients) were as fol-
lows: multiorgan failure caused by a perioperative ster-
nal hemorrhage on day 7; persistent malignant arrhyth-
mia on day 21 (present preoperatively and noncontrol-
lable postoperatively); aortic dissection occurring 1
week postoperatively; and sudden death on day 13 after
the operation without a history of perioperative MI or
low-output syndrome. No death was directly related to
a cardiogenic shock caused by perioperative MI.
Among the 38 deaths that occurred in the CPB group,
28 (60%) were caused by postoperative hemodynamic
causes, including low cardiac output; 5 (13%) caused
by multiorgan failure; 4 (10%) caused by pulmonary
insufficiency; 1 (2.6%) caused by neurologic causes;
and 5 (13%) caused by miscellaneous causes.
Recurrence of angina. Five patients in the beating
heart operation group experienced early (<2 months)
recurrence of angina. One patient had an acute occlu-
sion of a PDA graft on the third postoperative day. He
underwent a successful percutaneous transluminal
coronary angioplasty of the distal right artery.
Interestingly, the distal anastomosis was patent and was
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Table V. Postoperative bleeding and transfusion need
Beating heart operation (n = 300) CPB (n = 1870) P value
Blood loss*
Operative 400 (50-1500); 250-500 400 (100-3500); 350-600 .0001
Postoperative 525 (0-3500); 325-775 575 (0-6850); 300-975 .008
Blood transfusion
Prevalence 31% 65% <.0001
RCP per patient† 2.7 ± 2.2 3.0 ± 2.8 .08
TBP per patient‡ 4.9 ± 7.4 6.7 ± 10.0 <.005
RCP, Red cell packs; TBP, total blood products.
*Results are expressed as median (minimum-maximum); 25th-75th percentile.
†Red cell packs per transfused patient.
‡Total blood products per transfused patient.
Table VI. Hematology and biochemistry
Beating heart operation (n = 300) CBP (n = 1870) P value
HB (g/L)
Preoperative 134 ± 16 137 ± 16 .003
Postoperative 88 ± 14 80 ± 11 .0001
Discharge 107 ± 13.5* 102 ± 15* .0001
Creatinine (mmol/L)
Preoperative 103 ± 30 107 ± 47 .15
Postoperative 105 ± 40 125 ± 69* <.0001
CK-MB (IU/L)†
Day 0 8 (1-85); 6-10 28 (0-619); 22-37 <.0001
Day 1 9 (0-258); 6-16 16 (0-429); 11-26 <.0001
Day 2 9 (1-140); 6-14* 10 (0-435); 7-15‡ .3
HB, Hemoglobin; CK-MB, creatine kinase MB.
*Variation within group: P = .0001 for each period.
†Results are expressed as median (minimum-maximum); 25th–75th percentile.
‡Variation within group: P < .01 for each period.
not related to the technical failure of the bypass. Three
other patients underwent follow-up coronary
angiograms 3 to 6 months after the operation. Of these,
2 showed patency of all grafts with diffused disease.
One showed occlusion of two vein grafts made on an
endarterectomized PDA and a third obtuse marginal
artery. These vessels were of small caliber (1.25 mm)
and were described as diffusely atheromatous. These 3
patients were treated medically. Another patient, who
did not have a follow-up angiogram but did have a
nuclear stress test, had a localized ischemic area and
was also treated medically.
Two patients had midterm (>2 months) recurrent
angina. One was reinvestigated by angiography. A
venous graft stenosis was found (2 cm from the proxi-
mal aortic anastomosis), and a successful percutaneous
transluminal coronary angioplasty was performed. The
other patient was treated medically. Both are in New
York Heart Association functional class I.
Midterm mortality rates. We report 9 midterm
deaths (>1 month) in the beating heart operative tech-
nique groups, and causes of death are presented in
Table VIII. There were only 2 cardiac-related deaths.
An 86-year-old patient died of chronic heart failure
subsequent to multiple pulmonary emboli. Unfortu-
nately, this condition was diagnosed only after the heart
operation. Another patient died 2 months postopera-
tively because of chronic heart failure.
Discussion
The advent of MIDCAB has sparked renewed inter-
est among surgeons in off-pump coronary artery revas-
cularization. Although initially seen as an ideal proce-
dure for the patient, because both the full sternotomy
and CPB run were avoided, the MIDCAB procedure
did not respond fully to original expectations. Anterior
thoracotomies may occasionally be more painful than
anticipated. The limited MIDCAB exposure to the
mediastinal territory, coupled with the need for single
lung deflation, makes the harvesting of the internal tho-
racic artery and subsequent coronary grafting substan-
tially more time consuming and technically more
demanding. Furthermore, because the usual space
afforded by conventional coronary artery bypass graft-
ing (CABG) through full sternotomy is compromised,
surgical complications necessitating urgent conversion
to CPB become more likely.
In terms of its applicability, the MIDCAB procedure
is mostly limited to patients with single-vessel disease,
which, for the average practice in our experience, rep-
resents about 5% of the cardiac operation caseload. The
conventional sternotomy, in addition to providing sur-
geons with an accustomed approach, allows them to
concentrate on the prime task (ie, CABG on the beat-
ing heart). This is probably an easier first step in evolv-
ing cardiac operations toward a less invasive procedure
by the elimination of CPB. Next, steps can focus on
achieving this beating heart operative procedure
through smaller incisions or port incisions. A conven-
tional sternotomy provides access to all coronary terri-
tories, thereby allowing full or complete revasculariza-
tion. More important, the retracted rib cage allows the
surgeon the ability to “verticalize” the beating heart to
gain access to the posterior arteries. Considering that
more than 70% of the surgical candidates have triple-
vessel disease, this beating heart approach with con-
ventional sternotomy is clearly applicable to a larger
group of patients.
Since the beginnings of CABG operations for coro-
nary atheromatous disease, the off-pump approach has
always been present. Anecdotally known in the
1950s,10 the beating heart operative technique was real-
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Table VII. Postoperative morbidity
Beating heart 
operation CPB 
(n = 300) (n = 1870) P value
Reoperation* 5% 8% .9
Atrial fibrillation 30% 31% .8
Infection 4.6% 6% .4
Pulmonary complication 10% NA
CVA and TCI 1.6% 1.6% .8
Postoperative IABP 0.8% 5% .002
MI 4.0% 4.2% .99
Postoperative inotropic 32% 34% .95
support
Hospital stay (d) 6.9 ± 7.3 7.5 ± 5.5 .1
NA, Not available; CVA, cerebrovascular accident; TCI, transient cerebral
ischemia; IABP, intra-aortic balloon pump.
*Reoperation for postoperative bleeding or dehiscence.
Table VIII. Midterm mortality rates
Postoperative 
Causes Age (y) period (wk)
Propafenone intoxication 77 8
Neurologic 78 12
Right heart failure 86 24
Abdominal 90 20
Tracheo-innominate fistula 74 5
Septic shock 61 13
Cardiac insufficiency 59 10
Chronic renal insufficiency 74 60
Suicide 63 8
ly launched by Kolesov1 in the 1960s. Even with the
introduction of CPB, some surgeons continued, mainly
for economic reasons, to perform beating heart opera-
tions and reported extensive series with excellent
results.11-13
Avoiding CPB is a major step in rendering CABG
less invasive. The inflammatory reaction initiated by
CPB has always been seen as a significant threat.3 CPB
initiation activates the contact system to produce
kallikrein, a powerful neutrophil activator. The comple-
ment system is also activated, producing anaphylatox-
in C3a, C4a, and C5a, all of which are vasoactive sub-
stances. The activated neutrophils can potentially
release many cytotoxic enzymes, and the monocytes,
although more slowly activated, express tissue factor
that initiates the extrinsic coagulation pathway. All
these substances cause edema, decrease myocardial
contractility, change vascular resistance, and mediate
the principal complications of CPB, such as bleeding,
thromboembolism, fluid retention, and temporary
organ dysfunction.14
In the present study two comparable cohorts of
patients in terms of age, sex distribution, and preopera-
tive risk factors underwent two different CABG tech-
niques. Only the prevalence of unstable angina was
slightly more prominent in the CPB group. The two
groups had a comparable average number of grafts per-
formed per patient, with similar graft distribution rela-
tive to the different coronary territory being grafted.
The rate of complete revascularization was greater than
90% in the beating heart operation group, and conver-
sion to CPB was inferior to 1%. Average ischemic time
was less in the beating heart operation group than in the
CPB group. Operative blood loss was substantially
lower in beating heart operations, as reflected by a
transfusion need that was halved in this group.
Furthermore, among the patients receiving transfu-
sions, fewer derivative blood products were adminis-
tered in the beating heart operation group. Post-
operative and discharge hemoglobin count was
significantly higher in the beating heart operation
group, whereas the rise in postoperative creatinine level
was very low compared with the CPB group. There was
a significant trend toward a better myocardial preserva-
tion in the beating heart operation group as outlined by
the lower rise in postoperative CK-MB and a less fre-
quent need for intra-aortic balloon pumps for left ven-
tricular assistance. This has already been reported by
Pfister and colleagues13 in a matched case study, as
well as by others.15,16 The operative mortality rate was
comparable in both groups; however, a larger propor-
tion of deaths in the CPB group was due to postopera-
tive low cardiac output syndrome. The rate of perioper-
ative MI, which includes Q-wave and non–Q-wave
infarction, was similar in the two groups, suggesting
that this complication is not dependent on technique.
Of notable interest among postoperative complica-
tions is the incidence of atrial fibrillation (AF), which
was comparable to the incidence reported by others
under similar circumstances.17 In contrast, Galloway
and coworkers,18 who recently published the first
report of the Port-Access International Registry, report-
ed a 5% rate of new onset of postoperative AF with
Port-Access CABG (with CPB). Being proposed as a
possible explanation for this decreased incidence is the
absence of right atriotomy incision and suture line, as
well as fewer atrial manipulations with the Port-Access
technique. Because right atrial manipulations are mini-
mal during beating heart operations, it is our opinion
that some other explanation may have to be given. The
length of the pericardiotomy might be a factor because
it is minimized during Port-Access operations.
There was no difference in the incidence of inotropic
support after the operation, infection, reintervention for
either postoperative bleeding or sternal dehiscence, and
cerebrovascular accident (CVA) in both groups.
However, the two CVAs that occurred in the beating
heart operation group were noted 4 and 5 days postop-
eratively subsequent to an AF episode. No case of deep
mediastinitis occurred in the beating heart operation
group, and no patient had acute respiratory distress
syndrome. Pulmonary complications reported (10%)
include prolonged intubation (>24 hours), persistent
atelectasis, and pneumothorax. This latter complication
seemed more frequent than expected and may be relat-
ed to the placement of the deep pericardial sutures.
During this maneuver, it is imperative to deflate the
lung to decrease the risk of damage from the pericar-
dial suture needle. The surgeon must be aware of this
possible complication and leave the pericardium pene-
tration as superficial as possible.
The low-CPB conversion rate reported in this series
is due to the strict adherence to the revascularization
strategy adopted from the onset of this series. It con-
sists of beginning with the most collateralized vessel
and providing forward flow in the graft as soon as pos-
sible to serve as a vascular backup for the next gener-
ally less-collateralized target vessel. All proximal anas-
tomoses were completed in the same partial
side-clamping. Furthermore, avoiding the crossclamp-
ing of the distal right coronary artery in case of non-
critical stenosis decreased the incidence of intraopera-
tive ventricular block. Occasional crossclamping of the
inferior vena cava by external snaring was found to be
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complimentary in the control of temporary rise of pul-
monary pressure with left ventricular overload. This
maneuver afforded time for the anesthesiologist to
readjust the intravenous nitroglycerin infusion, as well
as fluid administration.
The circumflex approach developed with deep peri-
cardial sutures allows the displacement of the heart
without having to directly manipulate the left ventricu-
lar wall. This, combined with Trendelenburg position-
ing of the patient, contributed to maintaining stable
hemodynamics, as reported experimentally.19 Hypo-
thermia, a problem that we initially encountered, was
successfully managed by raising the room temperature,
using an intravenous fluid rewarming device, and occa-
sionally using a commercial warm-air ventilated hood
device to cover the head and shoulders of the patient.
Limitations of the study. This study has significant
limitations. Most important, no systematic control
coronary angiographies were performed, albeit for eco-
nomic and logistic reasons, thereby limiting the assess-
ment of the beating heart operation itself. The first 12
patients were studied, and initial results were good
(100% patency; 95% good anastomotic result), encour-
aging us to pursue this approach, which was, at the
time, novel.20,21 The fact that the CPB cohort had to be
chosen from a noncontemporary period might obscure
the comparison in hospital stay between the two groups
given the recent trends associated with more aggressive
discharging. Also, only the short-term clinical follow-
up has been completed, and therefore it is possible that
other angina recurrences have not been reported.
Finally, only a real randomized study with angiograph-
ic control and long-term follow-up will confirm or dis-
prove the value of this procedure.
Areas of caution. We found the treatment of patients
with moderately enlarged ascending aorta (4.0-4.5 cm)
that do not necessitate aortic replacement to be a sig-
nificant area of caution. These patients do not tolerate
side-clamping well, which is likely to lead to aortic dis-
section. Two dissections occurred in this series, and one
was repaired immediately during the initial operation.
The other patient was discharged and returned 1 week
later with an acute dissection at the site of the clamp;
the patient died during the surgical attempt to correct
the dissection. Both patients had a moderately enlarged
ascending aorta.
Reoperative operations were occasionally problemat-
ic when a patent venous graft fed a native occluded
artery. The side-clamping of the aorta is poorly tolerat-
ed in these circumstances, and the surgeon has to rely
on internal thoracic arteries when they are available.
Another problematic situation relates to ischemic
mitral insufficiency. Although CABG can be per-
formed by using the beating heart operative approach
in these cases, it does not alleviate the need for a mitral
annuloplasty. We now routinely do intraoperative stress
transesophageal echocardiography to determine the
need for such a procedure.
Conclusion
Systematic beating heart operative technique through
a sternotomy incision is an alternative to conventional
CABG on CPB for achieving complete coronary artery
revascularization, provided an adequate technique for
heart positioning and coronary stabilization. Every sur-
geon must negotiate a progressive learning curve in
attempting increasingly more difficult operations with
posterior revascularizations. Long-term clinical and
radiologic studies will be necessary to conclusively
substantiate these initial results.
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Discussion
Dr Stephen B. Colvin (New York, NY). I greatly enjoyed
this thorough review of off-pump CABG experience over 2
years by a single surgeon. The safety and efficacy of off-
pump CABG are repeatedly being validated. Questions still
remain as to the long-term results and even some early
adverse myocardial problems. Clearly, there are some other
advantages for patients having minithoracotomies versus
sternotomies, such as there being no sternal wound problems
and minithoracotomy seeming to avoid some of the respira-
tory problems and allowing for a shorter recovery time and
less stay in the hospital. These are being documented both for
MIDCAB and for Port-Access CABG.
Over 25 years at New York University (NYU), early on
some patients would have an off-pump bypass through a ster-
notomy, such as those patients who had a failed angioplasty
procedure or patients who were operated on through the left
side of the chest for obstructions in the circumflex graft that
needed an isolated marginal bypass.
Currently, all surgical modalities are being used: ster-
notomies with CPB, blood cardioplegia or cold fibrillation,
off-pump bypasses, Port-Access operations, MIDCAB, and
transmyocardial revascularization. About 45% of the patients
now have traditional bypass procedures, 25% have Port-
Access operations, 25% have off-pump CABG, and about 5%
have MIDCAB. There has been a recent rise in the percent-
age of off-pump procedures with improved stabilization, such
as suction in the Octopus II tissue stabilizer (Medtronic, Inc,
Minneapolis, Minn), mechanical devices, “misters,” and
improved tricks for exposure.
Most of us at NYU believe that minithoracotomies for
mitral and aortic valve surgery have significant benefits, and
we have somewhat of a bias toward minithoracotomies. We
generally use off-pump CABG for our increasing patient pop-
ulation with increased risk, such as the atheromatous aorta or
hepatic or renal insufficiency, including patients requiring
liver transplantation and those needing revascularization
before those procedures.
Our results with Port-Access cardiac bypass have shown
excellent results with excellent patency. Hospitalization and
transfusion costs are reduced, and recovery is quicker.
This excellent study has tremendous potential but really
does not show much in the way of decreased mortality or
morbidity rates. Still, there is a significant problem with dis-
sections, wound infections, and the need for inotropic agents,
as well as respiratory problems, despite not using the pump.
There is an expanding use of this approach with improved
technology, and I think that in a subset of patients, it has
tremendous application. However, we must be cautious of the
outcomes because early reports have shown late problems
with some of the grafts that were done on the beating heart
compared with those done with CPB.
Clearly, there is a subset that can be best treated with off-
pump CABG, but it remains to be seen what the benefits are
supposed to be for all patients if complications remain com-
parable with coronary bypass operations done on-pump,
given the better long-term results that we have all seen with
CABG done while on-pump.
Dr Cartier. Thank you, Dr Colvin, for your remarks. I
agree with you that we will need a long-term study to confirm
these findings, but I would say that the task of beating heart
surgery is not necessarily to show that it is a better procedure
than the standard operation but that it is at least as good. If we
can just prove that, it will be something that is very interest-
ing. We can decrease the cost, we can decrease the transfu-
sions, and I believe that for the older patient, outcomes are
going to be better.
It is obvious that the Heartport technology (Heartport, Inc,
Redwood City, Calif) with the minithoracotomy coupled with
the fact that you can do 3 or 4 bypasses through a small tho-
racotomy could be very interesting to the young population,
and I would be very happy to do a study in which these two
technologies are compared.
However, as you know, the Heartport technology has not
been introduced in Canada yet, and therefore it is not some-
thing we have been able to do. In the future, however, I
believe we will be able to compare these two techniques and
find out which is the worst for younger patients, sternotomy
or bypass, and which is the best for the older patients.
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